GLP-1 medications are real , the clinical evidence behind them is substantial, and the telehealth platforms offering access to GLP-1 prescriptions have expanded weight management care in ways that simply weren't available a few years ago
Boxed warning context
Educational Opportunities Professionals can leverage cagrilintide knowledge by: Client education Helping clients understand peptide therapy basics, realistic expectations, and the importance of medical supervision Professional development Staying current with metabolic health innovations positions practitioners as knowledgeable resources Collaborative care Understanding dosing protocols facilitates better communication with prescribing providers Outcome monitoring Supporting clients in tracking metrics and recognizing response patterns Supporting Clients on Peptide Protocols When working with individuals using cagrilintide or similar peptides: Lifestyle optimization remains crucial
doi: 10.1016/j.jacc.2020.08.045 7 SwiatkiewiczIPatelNTVillarreal-GonzalezMTaubPR
2 Conditions associated with pseudo-Hutchinson sign include Bowen disease, subungual squamous cell carcinoma, fungal infection, ethnic (racial) melanonychia, Peutz-Jeghers syndrome, Laugier-Hunziker syndrome, systemic disease (systemic lupus erythematosus, scleroderma), radiation therapy, AIDS, congenital nevus, drug-induced dyschromia, malnutrition, chronic trauma, and subungual hematoma
